REG - Societe Generale SA Willis Towers Watson - Form 8.3 - Willis Towers Watson plc

Willis Towers WatsonAnnouncement

09/06/2021 07:05

RNS Number : 2879B
  
Societe Generale SA
  
09 June 2021
  
 

Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


Société Générale S.A.




Company dealt in


               Willis Towers Watson plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.000304635 ordinary shares




Date of dealing


08/06/2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 




 


Long


Short




Number


(%)


Number


(%)




(1) Relevant securities


1,348,900


1.05


1,562


0.00




(2) Derivatives (other than options)


1,136


0.00


600,127


0.47




(3) Options and agreements to purchase/sell


0


0.00


0


0.00




Total


*1,590,860


*1.23


601,689


0.47




                                
* Include the holding of 240,824 shares on borrow products
 
                
(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
 




Class of relevant security:


Long


Short




 


Number


(%)


Number


(%)




(1) Relevant securities


 


 


 


 




(2) Derivatives (other than options)


 


 


 


 




(3) Options and agreements to purchase/sell


 


 


 


 




Total


 


 


 


 




 
 
Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




Purchase/sale


Number of relevant securities


Price per unit USD (Note 5)




Purchase


100


254.3




Purchase


10


253.96




Purchase


60


253.96




Purchase


30


253.96




Purchase


62


252.58




Purchase


8


252.58




Purchase


72


254.21




Purchase


28


254.21




Sale


20


253.96




Sale


20


253.96




Sale


60


253.96




Sale


53


252.5




Sale


100


253.3




Sale


20


253.64




Sale


20


253.64




Sale


60


253.64




Sale


100


252.88




Sale


79


253.58




Sale


21


253.58




Sale


29


253.28




Sale


10


253.28




Sale


60


253.28




Sale


1


253.28




Sale


47


252.5




Sale


1


253.88




Sale


100


253.83




Sale


12


254.44




Sale


1


253.76




Sale


7


254.57




Sale


40


253.89




Sale


2,075


254.57




Sale


57


256.38




Sale


3,146


254.57




Sale


20


253.94




Sale


60


253.94




Sale


20


253.94




Sale


4


253.4




Sale


96


253.4




Sale


532


254.57




Sale


228


254.57




Total Purchases


370


 




Total Sales


7,099


 




 
Derivatives transactions (other than options transactions)
 




Product name,

e.g. CFD


Nature of transaction

(Note 6)


Number of relevant securities

(Note 7)


Price per unit USD

(Note 5)




 


 


 


 




 
(b)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
(c)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 





 

Ap21
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.
 
 
 
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            No
 




Date of disclosure


09/06/2021




Contact name


Société Générale - Disclosure team




Telephone number


+33 1 42 14 92 74




If a connected EFM, name of offeree/offeror with which connected


 




If a connected EFM, state nature of connection (Note 10)


 




 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEFIFEERTIAIIL